East Point Bio Strategy

Bringing you Commercial clarity across Investment & Portfolio decisions
In healthcare investing, risk is rarely just scientific.
It is commercial.
Markets are overestimated.
Adoption is misunderstood.
Differentiation is assumed.

Where we focus:

• Market validation beyond TAM 
• Adoption dynamics across stakeholders 
• Competitive positioning 
• Go-to-market feasibility 

Outcome:
Higher conviction. Lower commercial risk.
Evaluate an Opportunity Together